Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,94 USD | -2,34% | -4,08% | -21,67% |
Omzet 2023 * | - | Omzet 2024 * | - | Marktkapitalisatie | 3,1 mln. 2,92 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 * | - | Nettowinst (verlies) 2024 * | - | EV/omzet 2023 * | - |
Nettoliquiditeiten 2023 * | - 0 | Nettoliquiditeiten 2024 * | - 0 | EV/omzet 2024 * | - |
K/w-verhouding 2023 * |
-0,12
x | K/w-verhouding 2024 * |
-0,13
x | Werknemers | 18 |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 95,63% |
Recentste transcriptie over Eloxx Pharmaceuticals, Inc.
1 dag | -2,34% | ||
1 week | -4,08% | ||
Lopende maand | -6,00% | ||
1 maand | -12,15% | ||
3 maanden | -20,34% | ||
6 maanden | -50,53% | ||
Lopend jaar | -21,67% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Sumit Aggarwal
CEO | Chief Executive Officer | - | 01-04-21 |
Daniel Geffken
DFI | Director of Finance/CFO | 67 | 01-11-20 |
Ali Hariri
CTO | Chief Tech/Sci/R&D Officer | - | 08-09-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Steven Rubin
BRD | Director/Board Member | 63 | 01-05-14 |
Alan Walts
BRD | Director/Board Member | 64 | 01-04-21 |
Sumit Aggarwal
CEO | Chief Executive Officer | - | 01-04-21 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
18-04-24 | 0,94 | -2,34% | 8 256 |
17-04-24 | 0,9625 | -2,52% | 10 806 |
16-04-24 | 0,9874 | +0,75% | 4 108 |
15-04-24 | 0,98 | -3,92% | 18 123 |
12-04-24 | 1,02 | +4,08% | 1 168 |
uitgestelde koers OTC Markets, 18 april 2024 om 21:54 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-21,67% | 3,1 mln. | |
-3,30% | 102 mld. | |
+1,79% | 96,07 mld. | |
-0,44% | 21,66 mld. | |
-18,35% | 20,77 mld. | |
-7,45% | 18,53 mld. | |
-40,31% | 16,91 mld. | |
-26,84% | 13,79 mld. | |
+0,59% | 13,33 mld. | |
+20,86% | 10,94 mld. |